@FierceBiotech: Aveo guts its R&D operation, cutting two-thirds of its payroll. Item | Follow @FierceBiotech
@JohnCFierce: Eyeing an IPO, Genkyotex banks a $21M round for PhII study -- NOX inhibition. Story | Follow @JohnCFierce
@DamianFierce: Another roughly $65M in biotech VC announced today, making for a three-day total nearing $700M. | Follow @DamianFierce
> Cambridge, MA-based Tetragenetics will collaborate with MedImmune on antibody drug discovery research. Release
> 23andMe and Genentech plan to generate whole genome sequencing data for about 3,000 people in 23andMe's Parkinson's disease community. The goal of the collaboration is to identify new therapeutic targets for treating Parkinson's disease. Release
Medical Device News
@FierceMedDev: Graphene 'flying carpet' strips deliver two #cancer drugs, each to a different cell target. Article | Follow @FierceMedDev
@EmilyWFierce: Cancer Genetics gets nod to offer cancer testing in California. Story | Follow @EmilyWFierce
> FDA clears pivotal trial for permanent use of artificial heart. Story
> Shockwave's energy-delivering angioplasty balloon for PAD receives CE mark. Article
> New technology can spot cavities early, but is that necessary? News
Pharma News
@FiercePharma: Whistle-blowing Bayer sales rep wins again in wrongful termination suit. Article | Follow @FiercePharma
@CarlyHFierce: ICYMI yesterday: Bayer drafts 'Community' star to launch cult-favorite hangover cure in U.S. More | Follow @CarlyHFierce
> New study clears Merck's blockbuster Gardasil of MS risk. News
> Roche and GSK set for sales growth in this year's fast-spreading flu epidemic. Report
Drug Delivery News
> Palo Alto pain management startup Carbylan vies for $86M IPO. Article
> Blend Therapeutics receives $21M in Series B round. Item
> Australia's EnGeneIC receives $10M in Series B round for studies of anticancer delivery tech. News
> Graphene 'flying carpet' strips deliver two cancer drugs, each to a different cell target. Report
> NeuroDerm's subcutaneously delivered alternative to oral levodopa shows promise in Parkinson's trial. More
Diagnostics News
> HTG Molecular Diagnostics mulls $60M IPO for next-gen profiling technology. Report
> Illumina blazes into 2015 with plans for new California campus. News
> Molecular Dx maker CombiMatrix wins a battle in insurance fraud lawsuit. Article
> Cancer Genetics gets nod to offer cancer testing in California. More
> Israel's Itamar looks to China, Canada and beyond for growth. Story
Pharma Marketing News
> Do rival DTC campaigns help your own brand? Yes, a study shows--up to a point. Report
> FDA's marketing police wrote only 10 tickets in 2014. Story
> Whistle-blowing Bayer sales rep wins again in wrongful termination suit. More
> Pfizer complains, advertising watchdog acts against Novartis Theraflu promo. Article
> Bayer drafts 'Community' star to launch cult-favorite hangover cure in U.S. News